Glasgow-Blatchford Score for Acute Upper GI Bleeding
The Glasgow-Blatchford Score (GBS) is a pre-endoscopic risk stratification tool that uses readily available clinical and laboratory parameters to identify patients with acute upper gastrointestinal bleeding who are at low risk and can be safely managed as outpatients without early endoscopy. 1
What the Score Measures
The GBS predicts the need for clinical intervention (blood transfusion, endoscopic therapy, surgery) or death in patients presenting with acute UGIB. It does NOT require endoscopic findings, making it immediately applicable in the emergency department 1.
Score Components
The GBS includes the following variables 1:
- Hemoglobin level (sex-specific thresholds)
- Blood urea nitrogen (BUN)/urea level
- Systolic blood pressure
- Heart rate/pulse
- Presence of melena
- Presence of syncope
- Evidence of hepatic disease
- Evidence of cardiac failure
Each parameter is assigned points based on severity, with scores ranging from 0 to 23. Higher scores indicate greater risk.
Clinical Application and Risk Stratification
Low-Risk Patients (GBS 0-1)
Patients with a GBS of 0-1 can be safely discharged from the emergency department for outpatient investigation without hospitalization or early endoscopy 1, 2. This threshold has been validated with:
- Negative predictive value of 99.45% for adverse outcomes 3
- No adverse events in multiple validation studies 3, 4
The 2019 International Consensus Guidelines specifically recommend using GBS ≤1 to identify very low-risk patients who may not require hospitalization 2.
Intermediate to High-Risk Patients (GBS ≥2)
Patients scoring ≥2 require hospital admission and further evaluation. Within this group:
- GBS >10 is associated with significantly higher odds of requiring blood transfusion (OR 21.84) and hemostatic intervention (OR 5.085) 5
- GBS ≥8 patients are more likely to require monitored bed placement, transfusion, and interventions 6
Comparative Performance
The GBS outperforms other pre-endoscopic scoring systems 1:
- Superior to pre-endoscopic Rockall Score for identifying patients who need intervention (AUC 0.79 vs 0.62) 7
- Better discriminative ability than AIMS65 for predicting blood transfusion requirements 8
- Performs comparably to the complete (post-endoscopic) Rockall Score without requiring endoscopic findings 1
Important Clinical Caveats
The GBS was designed to identify low-risk patients who can be discharged, NOT to predict mortality. While it helps stratify bleeding severity, other scores like AIMS65 may better predict in-hospital mortality 8.
A score of 0 is the most conservative threshold, but extending to GBS ≤1 has been validated as safe in multiple populations 2, 3, 4. Some studies suggest GBS ≤2 may also be safe, though this requires local validation 4.
The score's calibration may vary across populations, particularly outside the UK where it was developed 8. However, validation studies in continental Europe and the US have confirmed its utility for identifying low-risk patients 4, 7.
Practical Implementation
A semi-automated GBS calculator can be integrated into emergency department workflows 6. The score should be calculated immediately upon presentation using initial vital signs and laboratory values. Patients with GBS ≤1 and no other indications for admission (such as significant comorbidities) can be safely discharged with arrangements for urgent outpatient endoscopy 2, 3.